Skin Aging
Conditions
Brief summary
This study will evaluate the efficacy of the DIME TBT Cream in improving the appearance and hydration of aged skin in comparison to a retinol cream. This study will last for 60 days. The study will be conducted as a single-arm trial in which all participants will use both the test product and the positive control product (0.1% Retinol Clinical Trial Lotion). Participants will be required to undertake questionnaires at Baseline, Day 30, and Day 60. Photos will be taken at Baseline, Day 30, and Day 60, and expert skin grading will take place at Baseline and Day 60.
Interventions
OTHERDime Beauty TBT Cream
Test product contains: Water, Ammonium Acryloyldimethyltaurate/VP Copolymer, Behenyl Alcohol, Dimethicone, Caprylic/Capric Tiglyceride, Cetearyl Alcohol, Dimethicone Crosspolymer, Glycerin, Glyceryl Stearate, Pentylene Glycol, 1,2-Hexanediol, Isododecane, Linoleic Acid, Caprylic/Capric/Succinic Triglyceride, Octadecene, Olea Europaea (Olive) Oil Unsaponifiables, Orobanche Rapum Extract, Phospholipids, Phytosterols, Polyglyceryl-6 Behenate, Polyglyceryl-6 Stearate, Propanediol, Pyrus Malus (Apple) Fruit Extract, Caprylic/Capric/Myristic/Stearic Triglyceride, Stearyl Dimethicone, Hydroxyacetophenone, Bakuchiol, Cetyl Ricinoleate, Tetrasodium Glutamate Diacetate, Tocopherol, Xanthan Gum.
OTHERPositive Control
Water, Glycerin, Caprylic/Capric Triglyceride, Helianthus Annuus (Sunflower) Seed Oil, Pentylene Glycol, 1,2-Hexanediol, Cetearyl, Alcohol, Glyceryl Stearate, PEG-100 Stearate, Dimethicone, Hydroxyacetophenone, Sodium Ascorbate, Tocopherol, Carbomer, Xanthan Gum, Retinol, PEG-40 Hydrogenated Castor Oil.
Sponsors
Citruslabs
Dime Beauty Co.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
Females aged 18-65. Have one or more of the following: visible fine lines and wrinkles, dry skin, reduced skin elasticity, or generally unhealthy skin. Must be willing to use two different skincare products, one on each side of their face for the duration of the trial. Have a smartphone or camera to take before-and-after selfies.
Exclusion criteria
Anyone not in good health. Anyone who has any chronic health conditions such as oncological or psychiatric disorders. Anyone who has any known serious allergic reactions that require the use of an Epi-Pen. Anyone who is pregnant, breastfeeding, or wanting to become pregnant over the next three months. Anyone who cannot/ will not commit to the study protocol. Anyone with a history of substance abuse.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in facial skin hydration. [Baseline to Day 60] | 60 days | Photos of the participants' face before and after the intervention will be evaluated for a change in this parameter by a board-certified dermatologist. |
| Changes in participants' perception of signs of skin aging. [Baseline to Day 60] | 60 days | Measured via participant-reported questionnaires. Questionnaires will be designed using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., Not at all) and 1 representing the least favorable/worst outcome (e.g., Severe). |
| Changes in participants' perception of facial skin hydration. [Baseline to Day 60] | 60 days | Measured via participant-reported questionnaires. Questionnaires will be designed using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., Not at all) and 1 representing the least favorable/worst outcome (e.g., Severe). |
| Change in the appearance of fine lines and wrinkles on the face. [Baseline to Day 60] | 60 days | Photos of the participants' face before and after the intervention will be evaluated for a change in this parameter by a board-certified dermatologist. |
| Change in participants' perception of the appearance of fine lines and wrinkles on the face. [Baseline to Day 60] | 60 days | Measured via participant-reported questionnaires. Questionnaires will be designed using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., Not at all) and 1 representing the least favorable/worst outcome (e.g., Severe). |
| Change in skin elasticity. [Baseline to Day 60] | 60 days | Measured via participant-reported questionnaires. Questionnaires will be designed using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., Not at all) and 1 representing the least favorable/worst outcome (e.g., Severe). |
| Changes in signs of skin aging. [Baseline to Day 60] | 60 days | Photos of the participants' face before and after the intervention will be evaluated for a change in this parameter by a board-certified dermatologist. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of participants perception of the visual changes in the signs of skin aging as a result of using the test product compared to the control product. [Baseline to Day 60] | 60 days | Measured via participant-reported questionnaires. Questionnaires will be designed using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., Not at all) and 1 representing the least favorable/worst outcome (e.g., Severe). The left side of the face and the right side of the face will be compared. |
| Comparison of the visual changes in the signs of skin aging as a result of using the test product compared to the control product. [Baseline to Day 60] | 60 days | Photos of the participants' face before and after the intervention will be evaluated for a change in this parameter by a board-certified dermatologist. The left side of the face and the right side of the face will be compared. |
Countries
United States
Outcome results
None listed